Suggested remit: To appraise the clinical and cost effectiveness of OrganOx metra within its CE mark for preserving donor livers for transplant.
Status In progress
Technology type Device
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
Process TA
ID number 5116

Project Team

Project lead Michelle Adhemar

Email enquiries


Key events during the development of the guidance:

Date Update
17 August 2022 (10:00) Scoping workshop
06 July 2022 - 03 August 2022 Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
06 July 2022 In progress. Scoping commenced
16 May 2022 • The topic was discussed at the Topic Selection Oversight Panel (TSOP) in March 2022. The panel concluded that the topic was suitable for a Technology Appraisal. Should the device receive positive NICE guidance as a TA and recommended for use, the recommendations set out in the NICE regulations section 7, will apply.
11 May 2022 Awaiting development

For further information on our processes and methods, please see our CHTE processes and methods manual